MedTrace Logo

Tailored Drug Titration Through Artificial Intelligence

NCT03397524 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-09-20

No results posted yet for this study

Summary

ARTERY is a randomized clinical trial that investigates the benefit of a predictive modeling artificial intelligence in improving the management of anti-hypertensive medication treatment.

Conditions

Interventions

OTHER

optima4BP

optima4BP will provide the treating physician with a treatment action recommendation for consideration.

Sponsors & Collaborators

Principal Investigators

  • Gabriela Voskerician · Optima Integrated Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-12-31
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03397524 on ClinicalTrials.gov